The use of puberty blocking drugs to treat adolescents with gender dysphoria or incongruence has recently come under scrutiny following a decision by the UK High Court. Three judges ruled that children under 16 were unlikely ...
Dec 10, 2020
0
4
Dr. Lisa Philp and Professor Colleen Nelson, from the QUT Faculty of Health's School of Biomedical Science, are developing drugs to fight advanced prostate cancer that could also prevent and or treat acute respiratory distress ...
Nov 16, 2020
0
28
A clinical trial designed to test existing drugs in the treatment of a rare blood cancer has been launched at the Universities of Warwick and Birmingham.
Oct 27, 2020
0
6
Myelodysplastic syndrome (MDS) is a bone marrow failure disorder characterized by intractable cytopenia and dysplastic hematological changes. MDS has a varied clinical course, with some patients remaining asymptomatic with ...
Oct 7, 2020
0
3
Endometrial cancer, which begins in the uterus within the layer of cells that form the uterine lining, has been on the rise over the past decade. Each year in the U.S., over 60,000 women are diagnosed with endometrial cancer, ...
Sep 21, 2020
0
2
The first UK study to estimate the proportion of womb cancers caused by an inherited cancer predisposition called Lynch syndrome has been carried out by The University of Manchester.
Sep 18, 2020
0
10
Scientists from Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago were the first to examine endothelial cells—one of the main sources of blood production—for clues as ...
Sep 8, 2020
0
3
Winship Cancer Institute of Emory University (Winship) and Emory investigators are testing whether an anticancer drug can reduce lung inflammation in hospitalized COVID-19 patients, possibly preventing the need for intubation ...
Jul 14, 2020
0
3
As many cancer patients will confirm, the chemotherapy prescribed to kill the disease is often more debilitating than the cancer itself, with a range of horrendous side effects.
Jun 18, 2020
0
0
A regular dose of aspirin to reduce the risk of inherited bowel cancer lasts at least 10 years after stopping treatment, research has revealed.
Jun 12, 2020
0
98
